Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
Huang G, Jiang H, Lin Y, Xia W, Luo Y, Wu Y, Cai W, Zhou X, Jiang X. Huang G, et al. Among authors: wu y. J Exp Clin Cancer Res. 2018 Jun 20;37(1):121. doi: 10.1186/s13046-018-0794-3. J Exp Clin Cancer Res. 2018. Retraction in: J Exp Clin Cancer Res. 2022 Jul 25;41(1):231. doi: 10.1186/s13046-022-02414-1 PMID: 29925408 Free PMC article. Retracted.
A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysis.
Huang J, Lu S, Wang J, Jiang L, Luo X, He X, Wu Y, Wang Y, Zhu X, Chen J, Tang Y, Chen K, Tian X, Shi B, Guo L, Zhu J, Sun F, Zhen Z, Zhang Y. Huang J, et al. Among authors: wu y. Cancer Med. 2023 Jul;12(13):14130-14137. doi: 10.1002/cam4.6079. Epub 2023 May 15. Cancer Med. 2023. PMID: 37183837 Free PMC article. Clinical Trial.
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China.
Hong Y, Song M, Lan Y, Wang J, Lu S, Zhang Y, Zhu J, Sun F, Huang J, Liu J, Xu J, Wu Y, Guo H, Cai R, Zhen Z, Que Y, Zhang Y. Hong Y, et al. Among authors: wu y. Front Immunol. 2023 Jun 9;14:1182751. doi: 10.3389/fimmu.2023.1182751. eCollection 2023. Front Immunol. 2023. PMID: 37359533 Free PMC article.
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.
Huang J, Zhu J, Jiang L, Xu J, Lin X, Chang J, Zhang X, Lu S, Sun F, Wang J, Que Y, Ye Z, Yang L, Yuan X, Cai W, Tian C, Wu Y, He X, Tang YL, Zhang Y. Huang J, et al. Among authors: wu y. Front Pharmacol. 2024 Jul 17;15:1419369. doi: 10.3389/fphar.2024.1419369. eCollection 2024. Front Pharmacol. 2024. PMID: 39086394 Free PMC article.
86,208 results
You have reached the last available page of results. Please see the User Guide for more information.